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Precise quantification of dialysis using continuous sampling of spent
dialysate and total dialysate volume measurement. The "gold standard"
method to evaluate the mass balances achieved during dialysis for a given
solute remains total dialysate collection (TDC). However, since handling
over 100 liter volumes is unfeasible in our current dialysis units, alternative
methods have been proposed, including urea kinetic modeling, partial
dialysate collection (PDC) and more recently, monitoring of dialysate urea
by on-line devices. Concerned by the complexity and costs generated by
these devices, we aimed to adapt the simple "gold standard" TDC method
to clinical practice by diminishing the total volumes to be handled. We
describe a new system based on partial dialysate collection, the continuous
spent sampling of dialysate (CSSD), and present its technical validation.
Further, and for the first time, we report a long-term assessment of dialysis
dosage in a dialysis clinic using both the classical PDC and the new CSSD
system in a group of six stable dialysis patients who were followed for a
period of three years. For the CSSD technique, spent dialysate was
continuously sampled by a reversed automatic infusion pump at a rate of
10 mI/hr. The piston was automatically driven by the dialysis machine:
switched on when dialysis started, off when dialysis terminated and held
during the by pass periods. At the same time the number of production
cycles of dialysate was monitored and the total volume of dialysate was
calculated by multiplying the volume of the production chamber by the
number of cycles. Urea and creatinine concentrations were measured in
the syringe and the masses were obtained by multiplying this concentra-
tion by the total volume. CSSD and TDC were simultaneously performed
in 20 dialysis sessions. The total mass of urea removed was calculated as
58038 and 60442 mmol/session (CSSD and TDC respectively; 3.1 1.2%
variation; r = 0.99; y = 0.92x —28.9; P < 0.001). The total mass of
creatinine removed was 146,941,143 and 150,071,195 j.mo1/session (2.2
0.9% variation; r = 0.99; y = 0.99x + 263; P < 0.001). To determine the
long-term clinical use of PDC and CSSD, all the dialysis sessions
monitored during three consecutive summers with PDC (during 1993 and
1994) and with CSSD (1995) in six stable dialysis patients were included.
The clinical study comparing PDC and CSSD showed similar urea
removal: 510 59 during the first year with PDC and 516 46
mmol/dialysis session during the third year, using CSSD. Protein catabolic
rate (PCR) could be calculated from total urea removal and was 1.05
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0.11 and 1.05 0.09 g/kg!day with PDC and CSSD for the same periods.
PCR values were clearly more stable when calculated from the daily
dialysate collections than when obtained with urea kinetic modeling
performed once monthly. We found that CSSD is a simple and accurate
method to monitor mass balances of urea or any other solute of clinical
interest. With CSSD, dialysis efficacy can be monitored at every dialysis
session without the need for bleeding a patient. As it is external to the
dialysis machine, it can be attached to any type of machine with a very low
cost. The sample of dialysate is easy to handle, since it is already taken in
a syringe that is sent directly to the laboratory. The CSSD system is
currently in routine use in our unit and has demonstrated its feasibility,
low cost and high clinical interest in monitoring dialysis patients.
Throughout the 30 year history of kidney replacement therapy
the ambition of renal physicians has changed greatly. The first
challenge for the pioneers was to overcome the brief survival time
for the patients included in their programs [1]. With the pro-
longed survival of end-stage renal failure patients, new conditions
secondary to dialysate replacement therapy have joined to the
panoply of pathologies associated with renal failure. A good
example of these new types of diseases is B2-microglobulin
amyloidosis [2]. While clinicians have adapted to the smooth
evolution of goals for dialysis therapy, they have not yet found a
unanimously accepted parameter to determine a dialysis prescrip-
tion and monitor dialysis delivery.
Since the National Cooperative Dialysis Study (NCDS) study,
the most widely accepted parameter to quantify the dialysis dose
has been KtIV [3]. Although it is probably not ideal, Kt/V has
been helpful in quantifying the delivered dialysis dose, however,
its main drawback has been the difficulty in calculating it accu-
rately. Survival itself has also been quite recently proposed as a
parameter to assess dialysis adequacy [4]. However, although
survival is unquestionably a parameter in cohort studies (mainly
retrospective ones), it is not helpful in prescribing dialysis for a
single patient at the bedside.
Another approach to assess dialysis dose and drive dialysis
prescription and delivery has been to use the spent dialysate. Total
dialysate collection (TDC), the "gold standard" technique, obvi-
ates bleeding the patients, and has wider possibilities for applica-
tion as it allows the assessment of removal of many different blood
compounds in addition to urea. However, the total collection of
the spent dialysate is too cumbersome to be performed in a
standard dialysis unit. Our group has previously proposed the
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partial collection of spent dialysate (PDC) as an alternative to the
total collection, with the aim of adapting the technique to the
practice of the standard dialysis units [5]. In addition to assessing
urea removal and derived nutritional parameters [6], PDC has
allowed us to precisely calculate Ca mass balances during hemo-
dialysis when studying secondary hyperparathyroidism [7]. The
first results of a commercially available PDC system have been
reported very recently by Charytan et al [8].
We have encountered several problems when using PDC in
clinical practice: its linked cost (the price of incorporating the kit
in the standard dialysis machines is high), the difficulty in handling
spent dialysate collected in the vessel and discarding the unused
volume while preserving the dialysis premises from bacterial
contamination, and keeping accurate determinations (thorough
mixing mandatory). Further, the potential retrograde bacterial
contamination of the dialysate tubing within the machine may
become dangerous when using high flux membranes, particularly
if on-line infusion fluids are prepared.
For all these reasons we have developed an alternative method
based upon the same approach as PDC. We aimed to evaluate
both the reliability of this new method in assessing solute removal
during dialysis, and the associated risks or benefits when using it
routinely, in comparison with the old PDC technique.
This report technically and clinically validates a new method
that consists of continuously sampling the spent dialysate with a
standard, commercially available syringe pump, reversed. The
measurements of urea and creatinine concentration in this fluid
allowed accurate calculations of the total balances for these two
compounds, when compared to the balances calculated with the
total dialysate collection. We consider it an easy and accurate
technique that is only a small added expense to dialysis equip-
ment. It can be adapted to any type of dialysis machine, and does
not have any risks of bacterial proliferation or dialysate contam-
ination.
METHODS
Patients
Technical assessment and validation of the method: Comparison
with the "gold standard" method (total dialysate collection). Six
stable end-stage renal patients already in the dialysis program of
our hemodiafiltration unit were included in the study. The mon-
itors were Fresenius A2008C (Fresenius AG, Bad Homburg,
Germany) modified for hemodiafiltration. Sterile infusate was
produced on-line by ultrafiltration of bicarbonate buffered dialy-
sate as previously described [9], The re-infusion rate was 80 to 100
ml/min. A complete description of our on-line hemodiafiltration
unit is reported elsewhere [10]. Twenty dialysis sessions were
monitored.
Long-term studies with partial dialysate collection or continuous
spent dialysate sampling. Six stable dialysis patients who had been
treated for three years in the unit were sequentially studied with
PDC and continuous sampling of spent dialysate (CSSD). They
were selected on the basis of being clinically stable, maintained in
the same week days and having identical dialysis shifts during the
three year period, to avoid any interference with the analysis. Two
men and four women who were 60 4 years old participated in
the study. Their respective nephropathies were: chronic glomer-
ulonephritis (2), analgesic riephropathy (1), APKD (1) and unde-
termined (2). Their blood pressures were 145 8/77 3, 146
5/76 2 and 148 8/79 3 during 1992, 1993 and 1994, and their
estimated dry weights were 53 5, 53.3 5 and 52.2 4 during
the respective time periods.
Urea kinetics were performed monthly in all of the patients in
our unit according to the methods of Farrell and Gotch [11] as
previously described [10]. This included blood flow determination
by timed bubble speed and assessment of angioaccess recircula-
tion with a three sample stop-flow technique as previously de-
scribed [12]. The Kt/V and protein catabolic rate (PCR) were duly
calculated with a three sample method, and K was measured in
vivo at the end of the first hour of the mid-week dialysis session.
The values obtained with both direct dialysate sampling and UKM
were compared during the three different periods of the long-term
clinical study.
Total dialysate collection
Total dialysate collection was performed as previously de-
scribed [7]. The spent dialysate along with the ultrafiltrate were
collected in a 200 liter drum containing a submersible pump that
had been previously calibrated for volume assessment. Sampling
for solute concentration analysis was obtained after mixing thor-
oughly with the incorporated pump to equilibrate the concentra-
tions throughout the spent dialysate (over 100 liters/dialysis
session).
Partial dialysate collection
The partial dialysate collection was performed via a time-driven
sampling pump in the waste tubing just before the drain. This
system regularly collected a constant volume of fluid consisting of
spent dialysate and ultrafiltrate, ejecting it at the bottom of a 2
liter vessel. The theoretical basis, the technical characteristics and
first experiences on assessing dialysis dose and urea kinetics with
partial dialysate collection have been reported elsewhere [5, 6].
We have also proven its accuracy and extended its use in assessing
Ca mass balances [7].
We used this system from 1989 through 1993. Subsequently
(1994), because of bacterial contamination problems, we changed
the inlet site of the tubing into the collecting vessel. It was moved
from the bottom to the top of the vessel with a solution of
continuity between the tubing and the vessel to avoid a direct
contact and putative retrograde bacterial colonization.
Continuous spent dialysate sampling technique
Dialysate volume measurement. The total dialysate produced
was measured by assessing the number of cycles for dialysate
production as well as the volume of dialysate produced in each
cycle.
(a) Number of dialysate production cycles. This was obtained by
electronically monitoring the number of electric pulses driving the
dialysate concentrate to the volumetric equilibrium module
(VEM). This pulse occurred every time the VEM was full of fluid.
Thus, the number of pulses precisely corresponded to the number
of times that the central dialysate production chamber reached
full volume (Fig. 1 shows the hydraulic schema of the dialysis
machine). The device had two different digital counters. They
were automatically switched on by a colorimetric device at the
moment when the blood reached the venous return to the patient
(bubble trap), and the machine was set at the dialysis position by
the nursing staff. One of the counters permanently added the
number of production cycles counted from the start to the end of
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Fig. 1. Schematic of the partial collection systems for the spent dialysate. A. Schematic of the first setting reported in [61. B. The setting of our CSSD
system that differs in (i) the sampling site, which is now immediately after the dialysate and not just before the drain to obviate contamination problems
we encountered previously; (ii) there is no pump, but a simple external infusion syringe with a reversed track to pull continuously the spent dialysate,
rendering the system applicable to any dialysis machine; and (iii) there is no handling of the partial dialysate collected, as the syringe is forwarded
directly to the laboratory for chemical analysis.
the dialysis session. The other one was arrested whenever the
bypass of the machine was switched on by any of the alarms
occurring during the dialysis session, and re-started the counting
when dialysis recommenced. Both counters were also definitely
stopped by the automatic colorimetric device at the moment when
the rinsing fluid reached the venous line during the process of
returning the blood to the patient. The first digital reading
represented the total number of dialysate production cycles that
occurred during the dialysis session. The second one represented
the total number of production cycles resulting in effective dialy-
sate. The subtraction of the latter from the first counter repre-
sented the number of dialysate production cycles with "ineffective
dialysate" (bypassed from the dialyzer).
(b) Volume of the production chamber. The volume of dialysate
produced each cycle was measured by collecting the total dialysate
produced and dividing the total dialysate collected by the number
of production cycles. This number was constant for all the
machines in the dialysis clinic and it has remained constant for a
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Table 1. Stability of the sample at room temperature. Serial determinations of urea and phosphate concentration (in mmol/liter)
Patient number 1 2 3 4 5 6
Urea hour 0 6 6.9 8.2 5.2 6.5 8.9
Urea hour 3 6 7 8.2 5.2 6.2 9
Urea hour 6 5.9 6.9 8.2 5.3 6.2 8.6
Urea hour 9 6 6.9 8.2 5.3 6.1 9
(hour 0-hour 9) 0 0 0 —0.1 0.4 —0.1
Phos. hour 0 0.36 0.47 0.3 0.2 0.36 0.44
Phos. hour 3 0.35 0.5 0.3 0.21 0.36 0.45
Phos. hour 6 0.35 0.47 0.27 0.19 0.33 0.44
Phos. hour 9 0.33 0.46 0.23 0.15 0.29 0.4
(hour 0-hour 9)" 0.03 0.01 0.07 0.05 0.07 0.04
a 0.033 0.069, NSh 0.045 0.0087, P < 0.05
follow-up period greater than three years. The VEM volumes
were 30.2 0.1 ml in vitro and in viva measurements. These values
have been obtained with a total collection of spent dialysate
totalling 2,388 liters.
Continuous sampling of spent dialysate
Site of sampling. The spent dialysate was sampled immediately
after leaving the dialyzer at the dialysate outlet.
Sampling technique. Vial SE 200 M infusion pumps (VIAL
MEDICAL, Brézins, France) were modified to obtain a continu-
ous aspiration of fluid, by reversing the rotation sense of the
driving engine. By this modification a regular and constant volume
of spent dialysate was obtained from the total spent dialysate. This
pump was automatically started, arrested and stopped by the same
device driving the counter of the effective dialysate production
cycles.
Fifty milliliter syringes were used in this study. At the end of the
dialysis procedure, the syringe was removed from the infusion
pumps and directly sent to the laboratory for chemistry determi-
nations (Kone autoanalyzer; KONE Inc., Finland), with no fur-
ther handling. Since the infusion pumps may be set at different
speeds, in subsequent studies we compared 20 ml and 50 ml
syringes and found identical results. For this reason, we are
presently using 20 ml syringes because of their lower cost and ease
of handling.
Protocol
(a) Technical study. The validity of the new CSSD technique
was assessed by comparison with total dialysate collection. The
volume assessment and the concentration measurements were
compared in both techniques. The variability of the concentration
measurements for urea and creatinine were assessed by multiple
blind determination in aliquot samples. Since during the dialysis
session several alarms in the machine may switch the "BY PASS"
security system, deviating the produced dialysate from the dia-
lyzer, we also assessed the difference between the total dialysate
produced and the total effective dialysate. Thus, the incidence and
effects of the "BY PASS" security system activation on the final
volume determinations and concentration results were studied.
The three systems of direct dialysis quantification (total dialy-
sate collection, partial dialysate collection with the 1994 version,
and CSSD) were performed simultaneously in seven dialysis
sessions. Following the analysis of these first data, we decided to
abandon PDC (1994 version) and pursued the study comparing
total dialysate collection and CSSD. They were simultaneously
performed in the other 20 dialysis sessions analyzed in the present
study. We had previously validated the PDC technique that was
used before 1994, comparing it to TDC [7].
(b) Clinical use of the CSSD. The six dialysis patients selected
for the study based on their proven clinical stability, were moni-
tored with PDC and subsequently CSSD during three years time.
Total urea and creatinine concentrations in spent dialysate were
measured at every dialysis session and the urea and creatinine
masses removed were calculated. Only the summer months (July,
August and September) were used for analysis in the six patients
in order to avoid the influence of seasonal eating changes on
comparing both techniques. PCR was also calculated from the
total mass of urea removed as previously described [5], and
compared to the values obtained with monthly performed UKM.
In 1993 the partial dialysate collection was performed as
previously described [5, 7]. During 1994, the partial dialysate
collection technique was modified as commented above. In 1995
CSSD was started. A total of 39 dialysis sessions per patient and
per year have been included for this study (total number of
dialysis sessions was 702).
Statistical analysis
The values retained for every patient represent the mean of the
39 dialysis sessions analyzed per patient and per year. Statistical
analysis was performed on the mean of these means, and the
results are expressed as mean SEM with N = 6 at every point of
the clinical study. The Wilcoxon test for paired data was used to
compare two different techniques. Correlation analysis was also
performed using the Pearson's R test. P values less than 0.05 were
considered significant. The SAS statistical software package (1994
version; SAS Institute, NC, USA) was used for the analysis.
RESULTS
Technical study
Laboratory variability and stability of the sample in the syringe over
time. We first assessed the variability in determining urea and
creatinine concentrations linked to the laboratory reproducibility.
A single sample of spent dialysate was aliquoted in six different
tubes, given six different identification names (corresponding to
patients treated in the unit) and sent to the laboratory for blind
determination of urea and creatinine sparsely included along with
another 12 samples. The magnitude of the range (maximum —
minimum/mean) was 2.9 and 2.3% for urea and creatinine,
respectively.
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Syringe Total collection
Fig. 2. Urea concentrations in the total dialysate and in syringe sample
taken in the CSSD system. The concentration values are similar in both
fluids.
Table 2. Total and partial dialysate collection as well as CSSD
simultaneously performed
Urea
concentration
mmol/liter
% Variation
of TDC
Creatinine
concentration
1umol/liter
% Variation
of TDC
TDC 5.4 0.5 0 128.5 12 0
CSSD 5.2 0.5 —3.8 126.5 11.9 —1.6
PDC 4.2 0.4 —22.3 112.4 9.6
Second, we tested the influence of the elapsed time between
sampling and laboratory determinations. Spent dialysate taken
both at the beginning and at the end of dialysis was assessed for
urea and phosphate concentrations in six patients, after leaving
the sample in the syringe at room temperature for three, six and
nine hours. As observed in Table 1, both urea and phosphate were
very stable up to six hours after sampling. By nine hours, while
urea remained remarkably constant, phosphate decreased signif-
icantly, probably because of pH instability and precipitation.
Phosphate determinations for total phosphate balance will not be
presented in this study. The same controls were performed for
creatinine with satisfactory results (data not shown).
Concentration measurements. Urea concentrations in TDC and
CSSD are presented in Figure 2. Both urea concentrations were
identical. The percentage variation of CSSD in regards to TDC
was 1.4 1.3%.
The urea concentrations observed with the three different
techniques (TDC, PDC-1994 and CSSD) simultanously per-
formed are shown in Table 2. The urea concentration obtained in
CSSD fluid was identical to that obtained in TDC. In contrast,
PDC (1994 modified) underestimated the urea concentration
value by 20% when compared to TDC.
Measurement of the volume from the impulsion counting. The
total volume weighed in the drum was 119.4 2.1 liters and that
calculated from the impulsion system was 119.4 2 liters. The
mean variation of the calculated volume when compared to the
observed volume in the TDC was 0.02 0.35%.
Total balance of urea. The total mass of urea eliminated by
dialysis is represented in Figure 3. The x axis represents the values
obtained with the CSSD and the y axis those observed with TDC.
The points are very closely located over the identity line. The
values obtained in the TDC and CSSD were statistically corre-
lated (r = 0.99; P < 0.000 1). The regression equation for urea had
a slope of 0.916, which represents near identity between the
excreted masses calculated with TDC and CSSD.
Total balance of creatinine. The total mass of creatinine elimi-
nated by dialysis is represented in Figure 4. The x axis represents
the values obtained with the CSSD and the y axis those observed
with TDC. The points are precisely over the identity line. The
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Fig. 3. Total mass of urea removed per dialysis session; comparison
between the values obtained with CSSD and those obtained with the total
dialysate collection. Both results were strongly correlated and very similar,
as proven by the r 0.99 and the slope of the regression line close to 1
(P < 0.001; a = 0.916; b = 28.9).
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Fig. 4. Total mass of creatinine removed per dialysis session; compari-
son between the values obtained with CSSD and those obtained with the
total dialysate collection. Both results were strongly correlated and near
identical (r = 0.99; P < 0.001; a = 0.993; b = 263).
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Fig. 5. Long-term clinical study of the total urea removed per dialysis
session. Total urea removal was assessed at every single dialysis session for
three consecutive years in six patients. These patients were selected
because their stability in their respective diseases, their dialysis shifts and
days of treatment. The values retained represent the summer dialysis
sessions (39 sessions/patient; a total of 234 dialysis sessions per year are
included), the bars correspond to the mean of the mean per patient; the
error bars represent the SEM for the 6 values. During 1993 we used the
previously described partial dialysate collection; in 1994 the tubing
bringing the spent dialysate sampled to the vessel was left on the top of the
vessel to avoid retrograde contamination, and from 1995 we started using
the reversed syringe that allows both contamination-free sampling and
generalization to every dialysis machine. Equivalent results were observed
during 1993 with PDC and 1995 with the reversed syringe. In 1994 there
was an artifactual decrease in urea removal that was due to bad mixing of
the collected spent dialysate and to bacterial proliferation.
Fig. 6. Long-term clinical study of the total creatinine removed per
dialysis session. The bars represent the same study as in Figure 5. Again,
the results obtained during the first period of PDC and with the reversed
syringe were identical. During the second year of PDC, the artifactual
decrease was lesser than that observed for urea. Note that while bacterial
contamination decreased urea concentration, it did not modi' the
creatinine content. Therefore, the decrease was mainly due to inadequate
mixing of the sample.
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Fig. 7. Long-term clinical study of the protein catabolic rate (PCR) for
the different study periods. Open bars represent the mean of PCR
obtained with the classical urea kinetic modeling (performed monthly in
our unit [9]). Hatched bars correspond to the PCR calculated with the
partial dialysate collection systems (1993 and 1994), and the solid bars the
PCR calculated with the reversed syringe system. The greatest difference
between the UKM and direct dialysate systems calculations was observed
in 1994 (P < 0.032). Both the known overestimation of PCR using UKM
and artifactual temporary underestimation in the PDC system used at that
time may be responsible for this difference. The PCR observed with direct
quantitative methods was identical in 1993 (PDC) and 1995 (reversed
syringe), and they did not differ significantly from the PCR calculated with
UKM (NS).
correlated to that calculated from PDC during the first period of
PDC (r = 0.98; P < 0.001) and also with that calculated with
CSSD (r = 0.96; P < 0.005). However, a lower r value was
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values obtained in the TDC and CSSD were statistically corre-
lated (r = 0.99; P < 0.0001). The regression equation for
creatinine had a slope of 0.999, showing that the values obtained
by CSSD and those observed with TDC are identical.
Clinical study
Long-term assessment of the daily removal of total urea and
creatinine using PDC and CSSD. The results are represented in
Figures 5 and 6, A 12% decrease in total urea mass in spent
dialysate was observed during the second PDC period (1994). The
values of the total mass of urea eliminated in the spent dialysate
calculated with CSSD were similar to those observed with the first
PDC period. By contrast, the total mass of creatinine removed
was not significantly different during the three different years
analyzed.
The protein catabolic rate was estimated both from the monthly
performed UKM, and from the every dialysis direct dialysate
sampling. Figure 7 shows the differences in the estimated PCR per
year according to the method used for calculation. The difference
in the PCR estimation using UKM or CSSD was —1.4 0.3,
15.1 0.05 and 10.5 3.1%, respectively, during the first and
second PDC, and the CSSD periods, respectively. The actual
absolute numbers obtained during 1993 (PDC) and 1995 (CSSD)
were remarkably the same (1.05 0.11 and 1.05 0.09). The
correlation analysis between both estimations (urea kinetic mod-
eling and direct dialysate quantification) are depicted in Figure 8.
The protein catabolic rate obtained with UKM was strongly
1993 1994 1995
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UKM calculations
Fig. 8. Long-term clinical study of the protein catabolic rate (PCR).
Comparison between the values obtained with CSSD and those obtained
with UKM. The point plotted represent the PCR obtained with the 39
dialysis sessions per patient and period studied (y axis) and the mean of
the three UKM values obtained monthly (x axis). Symbols are: (•) the
values obtained in 1993 (PDC) (r = 0.98;P < 0.001); (0) those observed
in 1994 [modified (inaccurate) PDC] (r = 0.77; P < 0.05); and (A) those
observed in 1995 with the reversed syringe (r = 0.96; P < 0.005).
observed between the PCR values obtained with UKM and those
obtained with PDC during the second period of PDC (r = 0.77;
P < 0.05).
DISCUSSION
The present study shows that CSSD is a reliable method in
reflecting the solute concentration observed in total dialysate
collection. Therefore, it is a suitable technique for determining
the total dialysate content of any solute we may wish to measure.
The long-term clinical study shows that CSSD is also reliable in
determining the protein catabolic rate of the stable patients. By
using all the dialysis sessions over a period of three months in the
calculations of PCR, the values obtained are subject to a very
small error. However, longer or shorter periods may be used
according to the desire of the clinician in charge of the patient.
Aiming to improve survival rates and quality of life in dialysis
patients, renal physicians have been seeking objective markers of
the delivered dialysis dose on which they could also rely upon for
calculating dialysis prescriptions. Kt/V is the parameter that has
been most widely used for this purpose [3, 13]. However, it
requires multiple determinations and complicated calculations to
estimate K and V. Each of these parameters is subject to error,
which unavoidably will diminish the accuracy of the Kt/V estima-
tion [14]. These margins of error include the real in vivo clearance
of the dialyzer used that may be variable through a single dialysis
procedure, the effective blood flow that may also be variable
during dialysis, blood access recirculation, the mathematical
model used to calculate V, the rebound in post-dialysis results,
and the efficiency of the dialysis system used [14, 15]. Further,
although it has been shown that a low KtIV indicative of under-
dialysis may be harmful for dialysis patients [16], there is no
agreement on the accuracy of Kt/V values in evaluating or
predicting morbidity and mortality in the dialysis population.
Finally, it is difficult to dissociate whether the differences in
morbidity and mortality are due to Kt/V of simply to modifications
in dialysis duration [17].
Probably because Kt/V has not fulfilled the expectations of
renal physicians, in recent years direct dialysis quantification
systems have been proposed. Some of them are based on sequen-
tial or on-line urea determinations incorporated in the dialysis
machines [18—21]. An alternative approach is based on the TDC
system and simplified techniques of TDC to determine a single
measurement in the collected dialysate. This approach seems
more simple and less expensive. PDC is the first example of this
approach, which has fulfilled its commitments in clinical research
[5—8].
In this paper we report our two year experience using PDC in
clinical practice. We have observed that, although PDC was very
reliable at the beginning, several problems appeared when pro-
longing its use over the second year. The main problems were
retrograde tubing contamination by the stagnant spent dialysate,
and underestimation of solute concentration and removal.
Bacterial contamination forced us to change our PDC system.
In 1995 we changed the site of sampling in the hydraulic circuit by
moving it away from the drain, and we also decided to use a closed
collection system that would not require any particular handling
of the spent dialysate to send it to the laboratory. The validation
of this new system, the continuous sampling of spent dialysate
(CSSD), and its clinical use have been presented in this paper.
Since we have adopted CSSD, we have observed a striking
decrease in the number of positive cultures in our systematic daily
cultures of the ultrapure dialysate filtration membranes. This
observation is particularly important when high flux membranes
and on-line infusion fluid are used, as in hemodiafiltration. These
good results have been confirmed throughout the 20 months we
have been utilizing CSSD.
Underestimation of the total urea removal using PDC in
clinical practice could be demonstrated during the second year of
PDC, when we simultaneously performed the three different
techniques, TDC, PDC and CSSD (Table 2). Two factors may
explain underestimation with PDC. First, it is known that bacterial
proliferation may decrease the concentration of urea in the
medium, as bacteria may release urease. We have also confirmed
this point by determining daily urea concentrations in the same
PDC left for several days at room temperature; we found a
decrease both in urea and phosphate concentrations that was
significantly correlated to the titration of colonies of bacteria
(data not shown). Second, changing the spent dialysate inlet from
the bottom to the top of the collecting flask (in a first attempt to
prevent retrograde contamination), resulted in a decreased mix-
ing of the sample, and since the sample for the laboratory was
taken from the upper part of the vessel, the concentration was
underestimated. We performed the sampling both at the top and
the bottom of the vessel and found a 15% mean difference,
confirming this point. Therefore, although PDC has been vali-
dated by our group and others [5—8], our long-term clinical
experience led us to abandon it.
A new version of commercially available PDC has been recently
validated by Charytan et al [8]. The system used by these authors
is also incorporated in Fresenius machines and uses a peritoneal
collection in back to replace the collection vessel [8]. Although
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this modification may partially prevent the contamination prob-
lems we described above, there is still a risk linked to the
introduction of the sampling pump system at the position it is
located, just before the drain. The total urea and creatinine
removal we obtained in our clinical study are in keeping with
those reported in Charytan et al's work [81, if the differences in the
dialysis technique (we used HDF with a supplementary removal
obtained by convection) and in sex distribution (our patient
population was mainly female, so there was a lower muscle mass
and creatinine generation) are taken into account. However, it is
noteworthy that we observed an increased incidence of bacterial
contamination of the dialysis monitors that forced us to abandon
PDC after one year of using this technique with the sampling
system at the same location as the commercially available system
[8]. This long lapse of time is required for bacterial colonization of
the hydraulic system of the dialysis monitor.
In summary, CSSD represents a further conceptual step in the
evolution of direct dialysate quantification by partial dialysate
collection. It is external to the dialysis machine, and as a conse-
quence is applicable to any type of machine. It is not a source of
bacterial contamination to the dialysis monitor and it is very easy
for the nursing staff to use. A supplementary argument to use
CSSD is its lower cost compared to that of the system proposed by
Fresenius (the cost is limited to the infusion pump and the
disposable is a 20 ml syringe). In addition, to validate CSSD with
the "gold standard" (total dialysate collection), we present a first
clinical study with more than 600 dialysis sessions included over a
three year period, showing that dialysis dose and urea balances
can be accurately measured with this technique. After having
experienced both direct dialysate quantification systems (PDC
and CSSD), we propose the use of CSSD as a safe and accurate
method for clinical research and practice.
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